Searched for
NICARDIA
Amnish Aggarwal on Torrent Pharma plan to acquire JB Chemicals, Jio Finance surge & IT and shipping stocksAmnish Aggarwal discusses Torrent Pharma's expensive acquisition of JB Chemicals, anticipating long-term margin increases and synergies by ...- Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financingTorrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal inv...
- JB Pharma Q3 net profit jumps 22% to Rs 162 croreJB Pharma on Tuesday reported a 22% year-on-year (Y-o-Y) jump in net profit to Rs 162 crore for the quarter ended December 31 led by strong...
- JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13%JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to...
- Alkem joins $3 bn race for JB Chem as Torrent pauses talksAlkem Laboratories, India's fifth-largest branded pharmaceutical company, is vying for JB Chemicals and Pharmaceuticals as KKR looks to sel...
- Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyoutTorrent Pharma and Zydus Lifesciences are vying to acquire JB Chemicals and Pharmaceuticals, with both firms shortlisted by KKR, the curren...
- JB Pharma open to more buys to grow branded biz shareJB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...
- JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 croreDomestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed m...
- JB Pharma bets big on chronic therapy for its growth aspirationsJB Chemicals & Pharmaceuticals is keen to explore new opportunities in the world of metabolics and improve its own chronic contribution to ...
- 6 stocks mutual funds have been betting on in 2022ET Wealth examines the shopping baskets of mutual funds to determine which were the six stocks that were most in demand this year.
- JB Chemicals rises 4% on KKR to buy majority stake in firmThe promoter family owns 55 per cent of the company while the rest is with the public.
- 2 good businesses with strong teams on top, but market is yet to rate themSerious investors constantly hunt for attractively-priced quality stocks.
- Buy J B Chemicals & Pharmaceuticals; target Rs 416: Anand RathiBuy J B Chemicals & Pharmaceuticals at a price target of Rs 416.
Load More
